NSERecord Date1 Jul 2026 · 1 Jul 2026, 12:44 pm
Record Date
Windlas Biotech Limited · WINDLAS
✦ AI SummaryDividend
Windlas Biotech Limited has announced the record date for the purpose of dividend for the financial year 2025-26 as July 16, 2026, and has recommended a dividend of Rs. 6.30 per equity share.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Windlas Biotech Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Jul-2026.
Attachments (1)
📄pdf
Download →
WINDLAS_01072026124322_Record_Date_16072026.pdf
View document text
Windlas Biotech Limited
Reg. Off.: 40/1, Mohabewala Industrial Area
Dehradun, Uttarakhand 248 110, India
Tel.:+91-135-6608000-30, Fax:+91-135-6608199
Corp. Off.: 705-706, Vatika Professional Point, Sector-66,
Golf Course Ext. Road, Gurgaon, Haryana 122 001, India
Tel.:+91-124-2821030
CIN-L74899UR2001PLC033407
July 1, 2026
To To
Listing / Compliance Department Listing / Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street, Mumbai – 400 001 Bandra Kurla Complex
Bandra (E), Mumbai – 400 051
BSE CODE: 543329 NSE SYMBOL: WINDLAS
Dear Sir/ Madam,
Sub: Intimation of 25th Annual General Meeting and Record Date
We wish to inform you that the 25th Annual General Meeting (AGM) of the Company is scheduled to be held on Thursday,
July 23, 2026 at 1.00 p.m. (IST) through Video Conferencing / Other Audio Visual Means.
Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, the Company has fixed Thursday, July 16, 2026, as the Record Date for the purpose of
determining the members eligible to receive dividend for the financial year 2025-26.
As informed earlier, the Board has recommended a dividend of Rs. 6.30/- per equity share i.e @126% on the face value
of equity share of Rs. 5/- each for the financial year 2025-26, subject to approval of the shareholders at the 25th AGM.
The dividend shall be subject to deduction of tax at source.
This is for your kind information and record.
Thanking you,
Yours faithfully,
For Windlas Biotech Limited
Ananta Narayan Panda
Company Secretary & Compliance Officer
www.windlas.com